5-[(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-N-[[6-(trifluoromethyl)pyridin-3-yl]methyl]pyridin-2-amine Dihydrochloride Dihydrate

被引：0
|
作者：
Kozanecka-Okupnik, Weronika [1 ]
Wurst, Klaus [2 ]
Neuner, Sandro [2 ]
Nerdinger, Sven [3 ]
Gelbrich, Thomas [4 ]
机构：
[1] Selvita Serv Sp zoo, Selvita Grp, Bobrzynskiego 14, PL-30348 Krakow, Poland
[2] Univ Innsbruck, Inst Gen Theoret & Inorgan Chem, Innrain 80-82, A-6020 Innsbruck, Austria
[3] Sandoz GmbH, Biochemiestr 10, A-6250 Kundl, Austria
[4] Univ Innsbruck, Inst Pharm, Innrain 52c, A-6020 Innsbruck, Austria
来源：
MOLBANK | 2023年 / 2023卷 / 02期
关键词：
crystal structure; hydrate; hydrogen bonding; kinase inhibitor; pharmaceuticals;
D O I：
10.3390/M1673
中图分类号：
O62 [有机化学];
学科分类号：
070303 ; 081704 ;
摘要：
The dihydrochloride salt of pexidartinib was synthesized and the crystal structure of its dihydrate was determined from single crystal data. The asymmetric unit consists of one formula unit. In the pexidartinib molecule, the N atom of the central pyridine ring and the pyridine-N atom of the pyrrolopyridine group are both protonated. The pexidartinib molecule forms N-H & BULL;& BULL;& BULL;O and N-H & BULL;& BULL;& BULL;Cl interactions with neighboring water molecules and chloride ions, respectively. Water/chloride (O-H & BULL;& BULL;& BULL;Cl) and water/water (O-H & BULL;& BULL;& BULL;O) interactions are also observed. Collectively, these intermolecular interactions result in a complex H-bonded framework structure.
引用
收藏
页数：4
相关论文
共 50 条
  • [41] 2-(1H-Pyrrolo[2,3-b]pyridin-2-yl)pyridine
    Huang, Ping-Hsin
    Wen, Yuh-Sheng
    Shen, Jiun-Yi
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O1943 - +
  • [42] Synthesis and crystal structure of complex of Ce（NO3）3 with N-（3-methyl-pyridin-2-yl）-formimidoyl-（3-methyl-pyridin-2-yl） hydrazone
    JIANG Yinzhi1
    2. Department of Applied Chemistry
    Science in China(Series B), 2004, (03) : 251 - 256
  • [43] Synthesis and crystal structure of complex of Ce(NO3)3 with N-(3-methyl-pyridin-2-yl)-formimidoyl-(3-methyl-pyridin-2-yl) hydrazone
    Jiang Yinzhi
    Hu Weixiao
    Science in China Series B: Chemistry, 2004, 47 : 251 - 256
  • [44] Synthesis of the fused heterobicycles 5-pyridin-2-yl-thieno[3,2-b]pyridine, 6-pyridin-2-yl-thieno[2,3-b]pyridine and 6-pyridin-2-yl-thieno[3,2-c]pyridine
    Nurkkala, LJ
    Steen, RO
    Dunne, SJ
    SYNTHESIS-STUTTGART, 2006, (08): : 1295 - 1300
  • [45] Synthesis of N-(6-(4-(Piperazin-1-yl)phenoxy)pyridin-3-yl) benzenesulfonamide Derivatives for the Treatment of Metabolic Syndrome
    Deka, Nabajyoti
    Bajare, Swapnil
    Anthony, Jessy
    Nair, Amrutha
    Damre, Anagha
    Patel, Dharmeshkumar
    B-Rao, Chandrika
    Sivaramakrishnan, H.
    Mutt, Shivaprakash Jagalur
    Wilankar, Chandan
    Marita, Rosalind
    INTERNATIONAL JOURNAL OF MEDICINAL CHEMISTRY, 2013, 2013
  • [46] Synthesis and Biological Activity Research of 4-Substitued-1-(2-methyl-6-(pyridin-3-yl)-nicotinoyl) Semicarbazides
    Hu, Hongyu
    Wu, Jun
    Yuan, Jianfeng
    Wang, Zhenni
    Li, Chenfan
    Yan, Xiaoyan
    Fang, Meijuan
    Zhao, Shengxian
    CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2019, 39 (09) : 2507 - 2514
  • [47] 5,6-Dimethyl-2-(pyridin-2-yl)-1-[(pyridin-2-yl) methyl]-1H-benzimidazole
    Geiger, David K.
    DeStefano, Matthew R.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2014, 70 : O365 - +
  • [48] Synthesis, Characterization, Biological, and Molecular Docking Studies of (Z)-N-Substituted-4-(Pyridin-2-yl)-6-(1H-Pyrrolo[2,3-b]Pyridin-4-yl)Pyrimidin-2-Amine
    M. Arshad
    M. S. Akhter
    Russian Journal of Bioorganic Chemistry, 2022, 48 : 1068 - 1075
  • [49] Synthesis, Characterization, Biological, and Molecular Docking Studies of (Z)-N-Substituted-4-(Pyridin-2-yl)-6-(1H-Pyrrolo[2,3-b]Pyridin-4-yl)Pyrimidin-2-Amine
    Arshad, M.
    Akhter, M. S.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2022, 48 (05) : 1068 - 1075
  • [50] Discovery of N-(2-chloro-5-(3-(pyridin-4-yl)-1H-pyrazolo[3,4-b] pyridin-5-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide (FD274) as a highly potent PI3K/mTOR dual inhibitor for the treatment of acute myeloid leukemia
    Yang, Chengbin
    Chen, Yi
    Wu, Tianze
    Gao, Yunjian
    Liu, Xiaofeng
    Yang, Yongtai
    Ling, Yun
    Jia, Yu
    Deng, Mingli
    Wang, Jianxin
    Zhou, Yaming
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 258
12345